ResearchLong-Acting Injectable Antiretroviral Therapy as a Catalyst for Engagement in Opioid Use Disorder Treatment Among People with HIV Who Use Drugs
Jul 23, 2026Journal ArticlePut Us In, Coach: The Case for Recognizing the Infectious Disease/Addiction Workforce.Written by 2 Roon authors & 7 others Via Clinical Infectious Diseases
ResearchIncorporating preprints in systematic reviews: a preliminary study of a novel method for rapid evidence synthesis
ResearchConfidence score: a data-driven measure for inclusive systematic reviews considering unpublished preprints
ResearchImpact of Stigma on Clinician Training for Opioid Use Disorder Care: A Qualitative Study in a Primary Care Learning Collaborative
ResearchDecision-making Among Hepatitis C Virus-negative Transplant Candidates Offered Organs from Donors with HCV Infection
ResearchClinic screening for adverse childhood experiences in people living with HIV to Improve Care Delivery
ResearchThe impact of disease-related knowledge on perceptions of stigma among patients with Hepatitis C Virus (HCV) infection
ResearchValidation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infection
ResearchConcordance of hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode Statistics among patients treated with oral antidiabetic therapies
ResearchAbsolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study
ResearchPostauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes
ResearchValidity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs
ResearchEvaluation of methods to estimate missing days' supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)
ResearchDeterminants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs